![Teva Pharmaceutical Industries Limited 2022 Q2 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha Teva Pharmaceutical Industries Limited 2022 Q2 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha](https://static1.seekingalpha.com/uploads/sa_presentations/215/85215/slides/1.jpg?0)
Teva Pharmaceutical Industries Limited 2022 Q2 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 -August 02, 2023 at 07:13 am EDT | MarketScreener
![Teva Pharmaceutical Industries Limited 2022 Q2 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha Teva Pharmaceutical Industries Limited 2022 Q2 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha](https://static3.seekingalpha.com/uploads/sa_presentations/215/85215/slides/2.jpg?0)
Teva Pharmaceutical Industries Limited 2022 Q2 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
![Teva Pharmaceutical, Marathon Oil And 2 Other Stocks Insiders Are Selling - Kraft Heinz (NASDAQ:KHC), Marathon Oil (NYSE:MRO) - Benzinga Teva Pharmaceutical, Marathon Oil And 2 Other Stocks Insiders Are Selling - Kraft Heinz (NASDAQ:KHC), Marathon Oil (NYSE:MRO) - Benzinga](https://www.benzinga.com/files/images/story/2023/08/10/teva_pharmaceutical_-_logo.jpg)
Teva Pharmaceutical, Marathon Oil And 2 Other Stocks Insiders Are Selling - Kraft Heinz (NASDAQ:KHC), Marathon Oil (NYSE:MRO) - Benzinga
![Earnings Scheduled For February 8, 2023 - Trimble (NASDAQ:TRMB), Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga Earnings Scheduled For February 8, 2023 - Trimble (NASDAQ:TRMB), Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga](https://www.benzinga.com/files/images/story/2023/earnings_image_98.jpeg)
Earnings Scheduled For February 8, 2023 - Trimble (NASDAQ:TRMB), Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga
![Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit - Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit - Teva Pharmaceutical Indus (NYSE:TEVA) - Benzinga](https://www.benzinga.com/files/images/story/2023/07/05/teva.png)